Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gould

Showing results (681-690 of 696) with videos related to

Pageof 70
Sort By:
Health Technology Assessment (Winchester, England)|May 19, 2026
Enabling health and maintaining independence for older people at home: the 'HomeHealth' Randomised Controlled TrialKate Walters, Rachael Frost, Yolanda Barrado-Martín, et al.
Emerging Infectious Diseases|September 21, 2021
Burden of Influenza-Associated Respiratory Hospitalizations, Vietnam, 2014-2016Nguyen Cong Khanh, Ashley L Fowlkes, Ngu Duy Nghia, et al.
Western Pacific Surveillance and Response Journal : WPSAR|October 27, 2021
Environmental sampling for SARS-CoV-2 at a reference laboratory and provincial hospital in central Viet Nam, 2020Thái Hùng Đỗ, Văn Thành Nguyễn, Thế Hùng Đinh, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
1,3,4 Trisubstituted pyrrolidine CCR5 receptor antagonists bearing 4-aminoheterocycle substituted piperidine side chainsChristopher A Willoughby, Keith G Rosauer, Jeffery J Hale, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIVChristopher L Lynch, Jeffrey J Hale, Richard J Budhu, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Syntheses and biological evaluation of 5-(piperidin-1-yl)-3-phenyl-pentylsulfones as CCR5 antagonistsK Shankaran, Karla L Donnelly, Shrenik K Shah, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segmentMin Shu, Jennifer L Loebach, Kerry A Parker, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compoundsDong-Ming Shen, Min Shu, Christopher A Willoughby, et al.
Organic Letters|July 5, 2003
CCR5 antagonists: 3-(pyrrolidin-1-yl)propionic acid analogues with potent anti-HIV activityChristopher L Lynch, Jeffrey J Hale, Richard J Budhu, et al.
Health Technology Assessment (Winchester, England)|October 27, 2025
Acceptance and Commitment Therapy for people living with motor neuron disease: the COMMEND feasibility study and randomised controlled trialRebecca L Gould, Benjamin J Thompson, Charlotte V Rawlinson, et al.
Pageof 70

Showing results (681-690 of 696) with videos related to

Sort By:
Pageof 70
Health Technology Assessment (Winchester, England)|May 19, 2026
Enabling health and maintaining independence for older people at home: the 'HomeHealth' Randomised Controlled TrialKate Walters, Rachael Frost, Yolanda Barrado-Martín, et al.
Emerging Infectious Diseases|September 21, 2021
Burden of Influenza-Associated Respiratory Hospitalizations, Vietnam, 2014-2016Nguyen Cong Khanh, Ashley L Fowlkes, Ngu Duy Nghia, et al.
Western Pacific Surveillance and Response Journal : WPSAR|October 27, 2021
Environmental sampling for SARS-CoV-2 at a reference laboratory and provincial hospital in central Viet Nam, 2020Thái Hùng Đỗ, Văn Thành Nguyễn, Thế Hùng Đinh, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
1,3,4 Trisubstituted pyrrolidine CCR5 receptor antagonists bearing 4-aminoheterocycle substituted piperidine side chainsChristopher A Willoughby, Keith G Rosauer, Jeffery J Hale, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIVChristopher L Lynch, Jeffrey J Hale, Richard J Budhu, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Syntheses and biological evaluation of 5-(piperidin-1-yl)-3-phenyl-pentylsulfones as CCR5 antagonistsK Shankaran, Karla L Donnelly, Shrenik K Shah, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segmentMin Shu, Jennifer L Loebach, Kerry A Parker, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compoundsDong-Ming Shen, Min Shu, Christopher A Willoughby, et al.
Organic Letters|July 5, 2003
CCR5 antagonists: 3-(pyrrolidin-1-yl)propionic acid analogues with potent anti-HIV activityChristopher L Lynch, Jeffrey J Hale, Richard J Budhu, et al.
Health Technology Assessment (Winchester, England)|October 27, 2025
Acceptance and Commitment Therapy for people living with motor neuron disease: the COMMEND feasibility study and randomised controlled trialRebecca L Gould, Benjamin J Thompson, Charlotte V Rawlinson, et al.
Pageof 70